Medical Advisory Board

Our Medical Advisory Board (MAB) comprises a specialist multidisciplinary team of GIST experts from leading medical and academic institutions around the UK. They are the principal advisory group offering insight, scientific direction, and expertise for GIST Cancer UK’s research grant and infrastructure initiatives.

Purpose

The Medical Advisory Board (MAB) advises the GIST Cancer UK Trustees regarding:
  • The long-range strategy of GIST Cancer UK for achieving its mission to improve treatments and finding a cure for GIST Cancer.
  • Proposals for new research grants.
  • Other matters upon which the GIST Cancer UK trustees request advice and recommendations.

The MAB typically consists of up to ten members, including a Chairman, who meet a minimum of once per year. The initial term of appointment of each member is three years with the option of renewing.

They collaborate with GIST experts and researchers world-wide to ensure the most up to date knowledge and perspectives on treatments for GIST patients and the ongoing work of GIST Cancer UK.

Board Membership

Our current Medical Advisory Board members...


Dr V. Ramesh Bulusu - Chair

Dr Bulusu is a national expert on gastrointestinal stromal tumours (GIST). Working with other specialists in this area, he has developed the national guidelines for the management of this tumour and has lectured, presented and published extensively on the subject.

He is actively involved in numerous clinical trials as a principal and co investigator and has been the consultant clinical lead for PAWS-GIST since its inception in November 2010.


Professor Ian Judson

- FRCP, Royal College of Physicians, London
- MD, University of Cambridge
- BA (Hons), Natural Sciences, Univesity of Cambridge
- MB, BChir, University of Cambridge

Professor Judson has specialised in the management of sarcomas for the past 20 years and has made a particular study of gastrointestinal stromal tumours (GIST).


Professor Andrew Hall

- Retired Director, Northern Institute for Cancer Research
- Retired Director, Newcastle Biomedicine Biobank
- Designated Individual for Human Tissue Act Research Licence for Newcastle University
- Professor of Experimental Haematology
- Honorary Consultant Haematologist, Newcastle upon Tyne NHS Foundation Trust
- Pathology Lead, NCRI Confederation of Cancer Biobanks

Professor Hall has been instrumental in setting up of the National GIST Biobank.


Dr Newton Wong

Consultant Histopathologist - BSc MRCP , MBChB, FRCPath, MD
Areas of interest:
- Molecular diagnostics;
- Gastrointestinal pathology;
- GIST


Professor Robin Jones

Medical oncologist specialising in the treatment of bone and soft tissue sarcomas. He has experience in conducting Phase I, II and III trials, as well as translational studies in sarcoma. He trained in medical oncology at the Royal Marsden Hospital and between 2010 and 2014 he was Head of the Sarcoma Program at the University of Washington / Fred Hutchinson Cancer Research Center in Seattle. His main research interest focuses on clinical trials of novel agents and immunotherapy in sarcoma.


Dr Ruth Casey

Dr Casey is a consultant in Endocrinology at Cambridge University NHS Foundation Trust. Dr Casey has a specialist clinical interest in hereditary endocrine neoplasia and endocrine cancer. Her research has focused mainly on the role of succinate dehydrogenase gene mutations in tumorigenesis and has a strong translational focus. Her interest in succinate dehydrogenase deficient tumours has led to her collaboration with the PAWS-GIST Clinic.


Dr Olivier Giger

Honorary Consultant in Molecular Histopathology and University Lecturer - MD, PhD

Dr Giger completed his medical and speciality training in Switzerland and was awarded an MD at the University of Zurich. He received a PhD from the University of Liverpool for his research on epigenetic changes in the tumour stroma. His area of expertise lies in gastrointestinal pathology and molecular pathology of solid tumours. His research interests include the tumour microenvironment, gastrointestinal stromal tumours and colorectal cancer.;


Dr Fiona McRonald

Genomics Programme Manager, National Disease Registration Service, Public Health England - BMedSc, PGDip (Genomic Medicine), MSc, PhD

Fiona is a scientist specialising in cancer genetics. Fiona joined Public Health England in July 2015, to develop a new workstream focusing on genetics, genomics and molecular diagnostics data. Her work spans both the National Cancer Registration and Analysis Service (NCRAS) and the National Congenital Anomaly and Rare Disease Registration Service (NCARDRS).


Dr Georgina Wood

University College London | UCL
MBBS MRCP(UK) MRCP(Oncology) BSc MSc PhD
Consultant Medical Oncologist, Sarcoma Unit, UCL
Georgina is a Consultant Medical Oncologist in London. She has a PhD in Tumour Biology.